Amygdalin Delays Cartilage Endplate Degeneration and Improves Intervertebral Disc Degeneration by Inhibiting NF-κB Signaling Pathway and Inflammatory Response

References

• Amorim AB, Simic M, Pappas E, et al. Is occupational or leisure physical activity associated with low back pain? Insights from a cross-sectional study of 1059 participants. Braz J Phys Ther. 2019;23(3):257–265. doi:10.1016/j.bjpt.2018.06.004
   PubMed Web of Science ®Google Scholar
• Stanislawska I, Mincewicz M, Cabak A, et al. Epidemiological aspects of low back pain. Adv Exp Med Biol. 2019;1176:47–52.
   PubMed Web of Science ®Google Scholar
• Kennon JC, Awad ME, Chutkan N, DeVine J, Fulzele S. Current insights on use of growth factors as therapy for intervertebral disc degeneration. Biomol Concepts. 2018;9(1):43–52. doi:10.1515/bmc-2018-0003
   PubMedGoogle Scholar
• Vadala G, Russo F, Di Martino A, Denaro V. Intervertebral disc regeneration: from the degenerative cascade to molecular therapy and tissue engineering. J Tissue Eng Regen Med. 2015;9(6):679–690. doi:10.1002/term.1719
   PubMed Web of Science ®Google Scholar
• The L. GBD 2017: a fragile world. Lancet. 2018;392(10159):1683. doi:10.1016/S0140-6736(18)32858-7
   PubMed Web of Science ®Google Scholar
• Yan Z, Pan Y, Wang S, et al. Static compression induces ECM remodeling and Integrin alpha2beta1 expression and signaling in a rat tail caudal intervertebral disc degeneration model. Spine. 2017;42(8):E448–E458. doi:10.1097/BRS.0000000000001856
   PubMed Web of Science ®Google Scholar
• Newell N, Little JP, Christou A, Adams MA, Adam CJ, Masouros SD. Biomechanics of the human intervertebral disc: a review of testing techniques and results. J Mech Behav Biomed Mater. 2017;69:420–434. doi:10.1016/j.jmbbm.2017.01.037
   PubMed Web of Science ®Google Scholar
• Nguyen QT, Jacobsen TD, Chahine NO. Effects of inflammation on multiscale biomechanical properties of cartilaginous cells and tissues. ACS Biomater Sci Eng. 2017;3(11):2644–2656. doi:10.1021/acsbiomaterials.6b00671
   PubMed Web of Science ®Google Scholar
• Wu X, Li S, Wang K, et al. TNF-alpha regulates ITGbeta1 and SYND4 expression in nucleus pulposus cells: activation of FAK/PI3K signaling. Inflammation. 2019;42(5):1575–1584. doi:10.1007/s10753-019-01019-9
   PubMed Web of Science ®Google Scholar
• Ge Q, Ying J, Shi Z, et al. Chlorogenic Acid retards cartilaginous endplate degeneration and ameliorates intervertebral disc degeneration via suppressing NF-kappaB signaling. Life Sci. 2021;274:119324.
   PubMed Web of Science ®Google Scholar
• Sun J, Hong J, Sun S, et al. Transcription factor 7-like 2 controls matrix degradation through nuclear factor kappaB signaling and is repressed by microRNA-155 in nucleus pulposus cells. Biomed Pharmacother. 2018;108:646–655. doi:10.1016/j.biopha.2018.09.076
   PubMed Web of Science ®Google Scholar
• Wang S, Li J, Tian J, et al. High amplitude and low frequency cyclic mechanical strain promotes degeneration of human nucleus pulposus cells via the NF-kappaB p65 pathway. J Cell Physiol. 2018;233(9):7206–7216. doi:10.1002/jcp.26551
   PubMed Web of Science ®Google Scholar
• Cazzanelli P, Wuertz-Kozak K. MicroRNAs in intervertebral disc degeneration, apoptosis, inflammation, and mechanobiology. Int J Mol Sci. 2020;21(10):3601. doi:10.3390/ijms21103601
   PubMed Web of Science ®Google Scholar
• Wang Y, Che M, Xin J, Zheng Z, Li J, Zhang S. The role of IL-1beta and TNF-alpha in intervertebral disc degeneration. Biomed Pharmacother. 2020;131:110660. doi:10.1016/j.biopha.2020.110660
   PubMed Web of Science ®Google Scholar
• Zhang GZ, Liu MQ, Chen HW, et al. NF-kappaB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif. 2021;54(7):e13057. doi:10.1111/cpr.13057
   PubMed Web of Science ®Google Scholar
• Li Z, Wang X, Pan H, et al. Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-kappaB signaling pathways: implications for intervertebral disc degeneration. Osteoarthritis Cartilage. 2017;25(2):341–350. doi:10.1016/j.joca.2016.10.002
   PubMed Web of Science ®Google Scholar
• Guo J, Wu W, Sheng M, Yang S, Tan J. Amygdalin inhibits renal fibrosis in chronic kidney disease. Mol Med Rep. 2013;7(5):1453–1457. doi:10.3892/mmr.2013.1391
   PubMed Web of Science ®Google Scholar
• Jaswal V, Palanivelu J, R C. Effects of the Gut microbiota on Amygdalin and its use as an anti-cancer therapy: substantial review on the key components involved in altering dose efficacy and toxicity. Biochem Biophys Rep. 2018;14:125–132. doi:10.1016/j.bbrep.2018.04.008
   PubMedGoogle Scholar
• Baroni A, Paoletti I, Greco R, et al. Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells. Exp Dermatol. 2005;14(11):854–859. doi:10.1111/j.1600-0625.2005.00368.x
   PubMed Web of Science ®Google Scholar
• Hwang HJ, Kim P, Kim CJ, et al. Antinociceptive effect of amygdalin isolated from Prunus armeniaca on formalin-induced pain in rats. Biol Pharm Bull. 2008;31(8):1559–1564. doi:10.1248/bpb.31.1559
   PubMed Web of Science ®Google Scholar
• Hwang HJ, Lee HJ, Kim CJ, Shim I, Hahm DH. Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis. J Microbiol Biotechnol. 2008;18(10):1641–1647.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu J, Zhuo Y, et al. Amygdalin improves microcirculatory disturbance and attenuates pancreatic fibrosis by regulating the expression of endothelin-1 and calcitonin gene-related peptide in rats. J Chin Med Assoc. 2018;81(5):437–443. doi:10.1016/j.jcma.2017.09.005
   PubMed Web of Science ®Google Scholar
• Kung YL, Lu CY, Badrealam KF, et al. Cardioprotective potential of amygdalin against angiotensin II induced cardiac hypertrophy, oxidative stress and inflammatory responses through modulation of Nrf2 and NF-kappaB activation. Environ Toxicol. 2021;36(5):926–934. doi:10.1002/tox.23094
   PubMed Web of Science ®Google Scholar
• Si Z, Zhang B. Amygdalin attenuates airway epithelium apoptosis, inflammation, and epithelial-mesenchymal transition through restraining the TLR4/NF-kappaB signaling pathway on LPS-treated BEAS-2B bronchial epithelial cells. Int Arch Allergy Immunol. 2021;182(10):997–1007. doi:10.1159/000514209
   PubMed Web of Science ®Google Scholar
• Niu K, Zhao YJ, Zhang L, Li CG, Wang YJ, Zheng WC. 苦杏仁苷联合羟基红花黄色素A对IL-1β诱导的大鼠椎间盘软骨终板细胞的影响 [The synergistic effect of amygdalin and HSYA on the IL-1beta induced endplate chondrocytes of rat intervertebral discs]. Yao Xue Xue Bao. 2014;49(8):1136–1142. Chinese.
   PubMedGoogle Scholar
• Bian Q, Jain A, Xu X, et al. Excessive activation of TGFbeta by spinal instability causes vertebral endplate sclerosis. Sci Rep. 2016;6:27093. doi:10.1038/srep27093
   PubMed Web of Science ®Google Scholar
• Ni S, Ling Z, Wang X, et al. Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice. Nat Commun. 2019;10(1):5643. doi:10.1038/s41467-019-13476-9
   PubMedGoogle Scholar
• Miyagi M, Ishikawa T, Kamoda H, et al. Assessment of gait in a rat model of myofascial inflammation using the CatWalk system. Spine. 2011;36(21):1760–1764. doi:10.1097/BRS.0b013e3182269732
   PubMed Web of Science ®Google Scholar
• Miyagi M, Ishikawa T, Kamoda H, et al. Assessment of pain behavior in a rat model of intervertebral disc injury using the CatWalk gait analysis system. Spine. 2013;38(17):1459–1465. doi:10.1097/BRS.0b013e318299536a
   PubMed Web of Science ®Google Scholar
• Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine. 2002;27(23):2631–2644. doi:10.1097/00007632-200212010-00002
   PubMed Web of Science ®Google Scholar
• Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine. 1995;20(11):1307–1314. doi:10.1097/00007632-199506000-00022
   PubMed Web of Science ®Google Scholar
• Takahashi K, Aoki Y, Ohtori S. Resolving discogenic pain. Eur Spine J. 2008;17(Suppl 4):428–431. doi:10.1007/s00586-008-0752-4
   PubMedGoogle Scholar
• Sun HY, Hu KZ, Yin ZS. Inhibition of the p38-MAPK signaling pathway suppresses the apoptosis and expression of proinflammatory cytokines in human osteoarthritis chondrocytes. Cytokine. 2017;90:135–143. doi:10.1016/j.cyto.2016.11.002
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang K, Li X, et al. Wnt5a suppresses inflammation-driven intervertebral disc degeneration via a TNF-alpha/NF-kappaB-Wnt5a negative-feedback loop. Osteoarthritis Cartilage. 2018;26(7):966–977. doi:10.1016/j.joca.2018.04.002
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Liu H, et al. TNF-alpha enhances apoptosis by promoting chop expression in nucleus pulposus cells: role of the MAPK and NF-kappaB pathways. J Orthop Res. 2019;37(3):697–705. doi:10.1002/jor.24204
   PubMed Web of Science ®Google Scholar
• Shirazi-Adl A, Taheri M, Urban JP. Analysis of cell viability in intervertebral disc: effect of endplate permeability on cell population. J Biomech. 2010;43(7):1330–1336. doi:10.1016/j.jbiomech.2010.01.023
   PubMed Web of Science ®Google Scholar
• Wang Y, Videman T, Battie MC. ISSLS prize winner: lumbar vertebral endplate lesions: associations with disc degeneration and back pain history. Spine. 2012;37(17):1490–1496. doi:10.1097/BRS.0b013e3182608ac4
   PubMed Web of Science ®Google Scholar
• Oichi T, Taniguchi Y, Oshima Y, Tanaka S, Saito T. Pathomechanism of intervertebral disc degeneration. JOR Spine. 2020;3(1):e1076. doi:10.1002/jsp2.1076
   PubMedGoogle Scholar
• Urits I, Burshtein A, Sharma M, et al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr Pain Headache Rep. 2019;23(3):23. doi:10.1007/s11916-019-0757-1
   PubMed Web of Science ®Google Scholar
• Oichi T, Taniguchi Y, Soma K, et al. A mouse intervertebral disc degeneration model by surgically induced instability. Spine. 2018;43(10):E557–E564. doi:10.1097/BRS.0000000000002427
   PubMed Web of Science ®Google Scholar
• Bian Q, Ma L, Jain A, et al. Mechanosignaling activation of TGFbeta maintains intervertebral disc homeostasis. Bone Res. 2017;5:17008. doi:10.1038/boneres.2017.8
   PubMed Web of Science ®Google Scholar
• Rade M, Maatta JH, Freidin MB, Airaksinen O, Karppinen J, Williams FMK. Vertebral endplate defect as initiating factor in intervertebral disc degeneration: strong association between endplate defect and disc degeneration in the general population. Spine. 2018;43(6):412–419. doi:10.1097/BRS.0000000000002352
   PubMed Web of Science ®Google Scholar
• Xiao ZF, Su GY, Hou Y, et al. Mechanics and biology interact in intervertebral disc degeneration: a novel composite mouse model. Calcif Tissue Int. 2020;106(4):401–414. doi:10.1007/s00223-019-00644-8
   PubMed Web of Science ®Google Scholar
• Khan AN, Jacobsen HE, Khan J, et al. Inflammatory biomarkers of low back pain and disc degeneration: a review. Ann N Y Acad Sci. 2017;1410(1):68–84. doi:10.1111/nyas.13551
   PubMed Web of Science ®Google Scholar
• Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44–56. doi:10.1038/nrrheum.2013.160
   PubMed Web of Science ®Google Scholar
• Quero L, Klawitter M, Schmaus A, et al. Hyaluronic acid fragments enhance the inflammatory and catabolic response in human intervertebral disc cells through modulation of toll-like receptor 2 signalling pathways. Arthritis Res Ther. 2013;15(4):R94. doi:10.1186/ar4274
   PubMed Web of Science ®Google Scholar
• Chen F, Jiang G, Liu H, et al. Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1beta/NF-kappaB-NLRP3 inflammasome positive feedback loop. Bone Res. 2020;8:10. doi:10.1038/s41413-020-0087-2
   PubMed Web of Science ®Google Scholar
• Wu X, Liu Y, Guo X, et al. Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-kappaB pathway in rats. Cell Death Dis. 2018;9(2):98. doi:10.1038/s41419-017-0151-z
   PubMedGoogle Scholar
• Su X, Liu B, Gong F, et al. Isofraxidin attenuates IL-1beta-induced inflammatory response in human nucleus pulposus cells. J Cell Biochem. 2019;120(8):13302–13309. doi:10.1002/jcb.28604
   PubMed Web of Science ®Google Scholar
• Zhu L, Yu C, Zhang X, et al. The treatment of intervertebral disc degeneration using traditional Chinese medicine. J Ethnopharmacol. 2020;263:113117. doi:10.1016/j.jep.2020.113117
   PubMed Web of Science ®Google Scholar
• Tang F, Fan K, Wang K, Bian C. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-kappaB and Nrf2/NQO1 signalling pathways. Biomed Pharmacother. 2019;111:527–536. doi:10.1016/j.biopha.2018.12.096
   PubMed Web of Science ®Google Scholar
• Zhang A, Pan W, Lv J, Wu H. Protective effect of amygdalin on LPS-induced acute lung injury by inhibiting NF-kappaB and NLRP3 signaling pathways. Inflammation. 2017;40(3):745–751. doi:10.1007/s10753-017-0518-4
   PubMed Web of Science ®Google Scholar
• Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA. 1999;96(14):7710–7713. doi:10.1073/pnas.96.14.7710
   PubMed Web of Science ®Google Scholar